Proximal symphalangism

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:3250OMIM:185800Q70.9
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Proximal symphalangism (SYM1), also known as Cushing's symphalangism or hereditary symphalangism, is a rare genetic skeletal disorder characterized by bony fusion (ankylosis) of the proximal interphalangeal (PIP) joints of the fingers and, in some cases, the toes. The condition results from failure of normal joint formation during embryonic development. Affected individuals typically present with stiff, straight fingers due to the absence of functional proximal interphalangeal joints, with the ring and little fingers most commonly involved. The hands may appear relatively normal externally, but the inability to bend the affected joints leads to reduced grip strength and impaired fine motor function. In addition to the hand involvement, proximal symphalangism frequently affects other joints and structures. Conductive hearing loss is a common associated feature, resulting from fusion of the ossicles (small bones) in the middle ear, particularly the stapes. Some patients may also have fusion of carpal (wrist) or tarsal (ankle) bones. The condition is caused by heterozygous mutations in the NOG gene (encoding noggin) on chromosome 17q22 or, less commonly, in the GDF5 gene. Proximal symphalangism is allelic with multiple synostoses syndrome, representing a milder end of the same phenotypic spectrum. There is no cure for proximal symphalangism. Management is primarily supportive and symptomatic. Hearing aids may be beneficial for individuals with conductive hearing loss, and surgical intervention on the middle ear ossicles has been attempted in some cases. Occupational therapy can help optimize hand function. Surgical attempts to restore joint mobility in the fingers have generally been unsuccessful due to the fundamental absence of joint structures. Genetic counseling is recommended for affected families given the autosomal dominant inheritance pattern with high penetrance but variable expressivity.

Also known as:

Clinical phenotype terms— hover any for plain English:

Proximal symphalangismHP:0100264Elbow ankylosisHP:0003070Metacarpophalangeal synostosisHP:0005880Finger clinodactylyHP:0040019
Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Proximal symphalangism.

View clinical trials →

No actively recruiting trials found for Proximal symphalangism at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Proximal symphalangism community →

No specialists are currently listed for Proximal symphalangism.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Proximal symphalangism.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Proximal symphalangismForum →

No community posts yet. Be the first to share your experience with Proximal symphalangism.

Start the conversation →

Latest news about Proximal symphalangism

No recent news articles for Proximal symphalangism.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Proximal symphalangism

What is Proximal symphalangism?

Proximal symphalangism (SYM1), also known as Cushing's symphalangism or hereditary symphalangism, is a rare genetic skeletal disorder characterized by bony fusion (ankylosis) of the proximal interphalangeal (PIP) joints of the fingers and, in some cases, the toes. The condition results from failure of normal joint formation during embryonic development. Affected individuals typically present with stiff, straight fingers due to the absence of functional proximal interphalangeal joints, with the ring and little fingers most commonly involved. The hands may appear relatively normal externally, bu

How is Proximal symphalangism inherited?

Proximal symphalangism follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Proximal symphalangism typically begin?

Typical onset of Proximal symphalangism is neonatal. Age of onset can vary across affected individuals.